Madame Bioscience Public Company Limited
Madame Bioscience Public Company Limited, together with its subsidiaries, manufactures and sells plastic packaging in Thailand. The company operates through three segments: Packaging business; Food business; and Other business. It offers various food products, including frozen and chilled, plant based, hemp, sauce, dried fruit, and processed foods products under the Kitchen plus, Viiva, and LookC… Read more
Madame Bioscience Public Company Limited (MADAME) - Total Assets
Latest total assets as of September 2025: ฿1.81 Billion THB
Based on the latest financial reports, Madame Bioscience Public Company Limited (MADAME) holds total assets worth ฿1.81 Billion THB as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Madame Bioscience Public Company Limited - Total Assets Trend (2021–2024)
This chart illustrates how Madame Bioscience Public Company Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Madame Bioscience Public Company Limited - Asset Composition Analysis
Current Asset Composition (December 2024)
Madame Bioscience Public Company Limited's total assets of ฿1.81 Billion consist of 36.2% current assets and 63.8% non-current assets.
| Asset Category | Amount (THB) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ฿0.00 | 5.0% |
| Accounts Receivable | ฿284.08 Million | 17.6% |
| Inventory | ฿142.01 Million | 8.8% |
| Property, Plant & Equipment | ฿0.00 | 0.0% |
| Intangible Assets | ฿62.47 Million | 3.9% |
| Goodwill | ฿241.08 Million | 14.9% |
Asset Composition Trend (2021–2024)
This chart illustrates how Madame Bioscience Public Company Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Madame Bioscience Public Company Limited's current assets represent 36.2% of total assets in 2024, a decrease from 53.0% in 2021.
- Cash Position: Cash and equivalents constituted 5.0% of total assets in 2024, up from 2.6% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 17.0% of total assets, an increase from 4.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 17.6% of total assets.
Madame Bioscience Public Company Limited Competitors by Total Assets
Key competitors of Madame Bioscience Public Company Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
DXN HOLDINGS BHD.
KLSE:5318
|
Malaysia | RM2.00 Billion |
|
Dardanel Onentas Gida Sanayi AS
IS:DARDL
|
Turkey | TL171.33 Million |
|
Hainan Pearl River Holdings Co Ltd
SHE:000505
|
China | CN¥8.50 Billion |
|
Xiwang Foodstuffs Co Ltd
SHE:000639
|
China | CN¥6.08 Billion |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716
|
China | CN¥4.57 Billion |
|
CNFC Overseas Fishery Co Ltd
SHE:000798
|
China | CN¥5.88 Billion |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
|
China | CN¥40.64 Billion |
|
Xinjiang Chalkis Co Ltd
SHE:000972
|
China | CN¥1.25 Billion |
Madame Bioscience Public Company Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Madame Bioscience Public Company Limited generates 1.31x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Madame Bioscience Public Company Limited is currently not profitable relative to its asset base.
Madame Bioscience Public Company Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.98 | 0.72 | 0.72 |
| Quick Ratio | 0.87 | 0.48 | 0.48 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ฿-13.48 Million | ฿ -222.88 Million | ฿ -222.88 Million |
Madame Bioscience Public Company Limited - Advanced Valuation Insights
This section examines the relationship between Madame Bioscience Public Company Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.59 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -20.8% |
| Total Assets | ฿1.62 Billion |
| Market Capitalization | $15.14 Million USD |
Valuation Analysis
Below Book Valuation: The market values Madame Bioscience Public Company Limited's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Madame Bioscience Public Company Limited's assets decreased by 20.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Madame Bioscience Public Company Limited (2021–2024)
The table below shows the annual total assets of Madame Bioscience Public Company Limited from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ฿1.62 Billion | -20.76% |
| 2023-12-31 | ฿2.04 Billion | -17.02% |
| 2022-12-31 | ฿2.46 Billion | +55.03% |
| 2021-12-31 | ฿1.58 Billion | -- |